Increased capability to produce medicines for challenging diseases including cancer WALTHAM, Mass. — Thermo Fisher Scientific, the world leader in serving science, today expanded its manufacturing capacity in St. Louis to support biologic therapies for diseases ranging from cancers to auto immune conditions to rare genetic disorders. Thermo Fisher made a significant investment since 2021 […]

External placement marks a key milestone in the development of Evonetix’s benchtop DNA synthesis technology, in preparation for customer use and commercialization  Cambridge, UK – EVONETIX LTD (‘Evonetix’), the Company developing semiconductor scale technology to improve access to gene synthesis, today announced its first placement of a DNA synthesis development platform for evaluation at Imperial College […]

WASHINGTON — Danaher Corporation (NYSE: DHR) announced today that it has completed the separation of its Environmental & Applied Solutions segment, through the spin-off of Veralto Corporation. Veralto will begin “regular way” trading on the New York Stock Exchange on October 2, 2023, under the symbol “VLTO.” “Today marks an exciting milestone for Danaher. The successful spin-off of […]

World’s largest biomedical research resource now features more than 28 PB of data to help accelerate scientific discovery and improve human health MOUNTAIN VIEW, Calif.—DNAnexus, Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced that the DNAnexus-enabled UK Biobank Research Analysis Platform (UKB-RAP) community has grown to more than […]

Progress on Environment, Social and Governance (ESG) goals reflected in QIAGEN securing a „Prime“ rating and among the industry leaders with ISS-ESG rating Environment: Net-zero target validated by Science Based Targets initiative (SBTi), achieved 20% decrease in Scope 1 and 2 emissions, reduced plastic usage by 16.5% in 2022 Social: Increasing workforce diversity with 35% […]

Certification Validates Company’s Commitment to Quality in all Areas, Helping to Advance Roadmap for Translational and Clinical Markets in the United States FREMONT, Calif. — Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that it has received EN ISO 13485:2016 Quality Management System (QMS) certification. The certification applies to Cytek’s headquarters […]

BOSTON– 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announces that it has entered the initial production phase of the Aerosol and Vapor Chemical Agent Detector (AVCAD) program. The company and its partner on the project, Smiths Detection, will initially produce 122 systems in this next […]

Leica Microsystems has announced an exciting new collaboration with the Department of Biochemistry at The University of Oxford UK, in the fields of optical and super resolution microscopy, artificial intelligence, correlative microscopy and EM specimen preparation.  The Centre of Excellence will be hosted by the world-class Micron Bioimaging Facility within the Department of Biochemistry at […]

Reflects evolution of the Company from research and development towards scale-up and commercialization Cambridge, UK– EVONETIX LTD (‘Evonetix’), the Company developing semiconductor scale technology to improve access to gene synthesis, today announces the introduction of new branding to align with its vision to ‘Redefine possible’ through the development and commercialization of its benchtop semiconductor gene synthesis […]

MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today issued its 2023 Corporate Sustainability Report (CSR), detailing the continued progress advancing its Environmental, Social and Governance (ESG) initiatives. Bio-Techne’s CSR is organized around four key pillars: Our People, Advancing Science, Governance and Operational Integrity, and The Environment. Bio-Techne’s EPIC values (Empowerment, Passion, Innovation and Collaboration) remain the backbone […]